Formula & Concentration

VYVGART™ (efgartigimod alfa-fcab) injection, for intravenous use




VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

Product Options

Package Size



20 ml



Shelf Life and Storage

Store VYVGART vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until time of use. Do not freeze. Do not shake.

Storage Conditions of the Diluted Solution

  • VYVGART does not contain preservatives. Administer immediately after dilution and complete the infusion within 4 hours of dilution.
  • If immediate use is not possible, the diluted solution may be stored refrigerated at 2°C to 8°C (36°F to 46°F) for up to 8 hours. Do not freeze. Protect from light. Allow the diluted drug to reach room temperature before administration. Complete the infusion within 4 hours of removal from the refrigerator. Do not heat the diluted drug in any manner other than via ambient air.